Stock listing
TPEx:6939 TFBS Bioscience, Inc. (啟弘生技) 股價
Follow TFBS Bioscience, Inc. into a list and get an email when it puts out news.
Share price · TPEX:6939
$18.45 TWD -1.30 (-6.6%)
Close on Nov 20, 2026
- Day range
- $18.45 – $19.00 TWDNov 20, 2026
- Volume
- 16,500 sharesNov 20, 2026
- Market cap
- $652.8M TWDAt the close on Nov 20, 2026 · price × 35.38M shares outstanding
- 52-week range
- $17.10 – $27.85 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $592,633 TWDMedian day 15,530 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6939 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.45 | -1.30 | -6.6% | $18.85 | $19.00 | $18.45 | 16,500 | |
| $19.75 | +0.75 | +3.9% | $19.75 | $19.75 | $19.75 | 1 | |
| $19.00 | +0.45 | +2.4% | $19.15 | $19.80 | $19.00 | 17,051 | |
| $18.55 | -0.10 | -0.5% | $18.70 | $19.45 | $18.55 | 35,021 | |
| $18.65 | +0.30 | +1.6% | $18.50 | $18.65 | $18.50 | 1,010 | |
| $18.35 | -0.55 | -2.9% | $18.85 | $19.10 | $18.05 | 62,200 | |
| $18.90 | -0.50 | -2.6% | $19.75 | $19.75 | $18.90 | 12,003 | |
| $19.40 | +1.20 | +6.6% | $18.20 | $19.60 | $18.20 | 62,506 | |
| $18.20 | +0.05 | +0.3% | $18.20 | $18.20 | $18.20 | 50 | |
| $18.15 | 0.00 | 0.0% | $17.50 | $18.15 | $17.10 | 48,765 | |
| $18.15 | +0.15 | +0.8% | $17.80 | $18.15 | $17.60 | 40,002 | |
| $18.00 | -0.70 | -3.7% | $18.70 | $18.70 | $17.85 | 21,410 | |
| $18.70 | 0.00 | 0.0% | $17.90 | $18.70 | $17.90 | 4,010 | |
| $18.70 | +0.05 | +0.3% | $18.70 | $18.70 | $17.90 | 4,010 | |
| $18.65 | 0.00 | 0.0% | $18.70 | $18.70 | $17.90 | 11,020 | |
| $18.65 | +0.25 | +1.4% | $18.15 | $18.65 | $17.95 | 9,005 | |
| $18.40 | +0.50 | +2.8% | $17.90 | $18.70 | $17.90 | 20,310 | |
| $17.90 | -0.90 | -4.8% | $18.30 | $18.80 | $17.90 | 20,090 | |
| $18.80 | 0.00 | 0.0% | $18.80 | $18.80 | $18.80 | 0 | |
| $18.80 | +0.15 | +0.8% | $18.65 | $19.20 | $18.65 | 12,140 | |
| $18.65 | 0.00 | 0.0% | $19.15 | $19.15 | $18.65 | 11,030 | |
| $18.65 | +0.05 | +0.3% | $17.95 | $19.25 | $17.95 | 27,801 | |
| $18.60 | -0.45 | -2.4% | $19.15 | $19.15 | $17.95 | 61,201 | |
| $19.05 | -0.10 | -0.5% | $19.50 | $20.60 | $18.45 | 190,126 | |
| $19.15 | -0.15 | -0.8% | $19.35 | $22.80 | $18.95 | 342,905 | |
| $19.30 | +0.20 | +1.0% | $19.10 | $19.65 | $18.90 | 17,290 | |
| $19.10 | +0.05 | +0.3% | $19.10 | $19.10 | $19.10 | 5,000 | |
| $19.05 | +0.10 | +0.5% | $18.90 | $19.05 | $18.90 | 29,001 | |
| $18.95 | -0.75 | -3.8% | $19.00 | $19.10 | $18.95 | 28,200 | |
| $19.70 | +0.70 | +3.7% | $19.70 | $19.80 | $19.60 | 16,030 | |
| $19.00 | -0.50 | -2.6% | $19.85 | $19.85 | $19.00 | 1,001 | |
| $19.50 | 0.00 | 0.0% | $20.00 | $20.00 | $19.30 | 35,160 | |
| $19.50 | 0.00 | 0.0% | $20.40 | $20.40 | $19.40 | 29,019 | |
| $19.50 | -0.20 | -1.0% | $19.50 | $19.50 | $19.50 | 1,000 | |
| $19.70 | +0.10 | +0.5% | $19.70 | $19.90 | $19.55 | 32,120 | |
| $19.60 | -0.95 | -4.6% | $20.60 | $20.60 | $19.60 | 15,030 | |
| $20.55 | +1.00 | +5.1% | $20.30 | $20.55 | $19.85 | 9,021 | |
| $19.55 | +0.25 | +1.3% | $19.40 | $19.85 | $19.20 | 22,000 | |
| $19.30 | +1.10 | +6.0% | $18.55 | $19.30 | $18.55 | 9,000 | |
| $18.20 | -2.00 | -9.9% | $20.50 | $20.85 | $18.05 | 149,569 | |
| $20.20 | -0.55 | -2.7% | $20.20 | $20.20 | $20.20 | 1,501 | |
| $20.75 | +0.75 | +3.8% | $20.00 | $20.85 | $19.95 | 34,000 | |
| $20.00 | 0.00 | 0.0% | $20.00 | $20.00 | $20.00 | 100 | |
| $20.00 | +0.95 | +5.0% | $20.00 | $20.00 | $19.10 | 6,495 | |
| $19.05 | -0.55 | -2.8% | $19.80 | $19.80 | $19.05 | 6,020 | |
| $19.60 | -0.30 | -1.5% | $20.00 | $20.05 | $19.30 | 64,005 | |
| $19.90 | +0.80 | +4.2% | $18.90 | $19.90 | $18.85 | 132,770 | |
| $19.10 | 0.00 | 0.0% | $18.90 | $19.10 | $18.90 | 6,000 | |
| $19.10 | -0.40 | -2.1% | $19.10 | $19.30 | $19.00 | 39,820 | |
| $19.50 | +0.40 | +2.1% | $19.75 | $19.75 | $19.50 | 7,000 | |
| $19.10 | -0.10 | -0.5% | $19.00 | $19.20 | $19.00 | 4,000 | |
| $19.20 | -0.60 | -3.0% | $19.00 | $19.20 | $19.00 | 6,000 | |
| $19.80 | -0.05 | -0.3% | $19.10 | $19.85 | $19.00 | 12,100 | |
| $19.85 | +0.30 | +1.5% | $19.85 | $19.85 | $19.85 | 3,100 | |
| $19.55 | -0.45 | -2.2% | $19.00 | $19.55 | $19.00 | 39,001 | |
| $20.00 | +0.25 | +1.3% | $20.00 | $20.00 | $19.20 | 2,101 | |
| $19.75 | -0.30 | -1.5% | $20.00 | $20.00 | $19.20 | 50,470 | |
| $20.05 | -0.30 | -1.5% | $19.60 | $20.80 | $19.60 | 18,002 | |
| $20.35 | +0.70 | +3.6% | $19.65 | $21.40 | $19.65 | 56,379 | |
| $19.65 | 0.00 | 0.0% | $19.65 | $19.65 | $19.65 | 1,500 | |
| $19.65 | 0.00 | 0.0% | $19.65 | $19.65 | $19.65 | 1,500 | |
| $19.65 | +0.90 | +4.8% | $19.65 | $19.65 | $19.65 | 1,000 |
Splits
1 split · TPEX:6939 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 26-for-25 | Split |
- Ticker
- TPEx:6939
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TPEx
- Currency
- TWD
TFBS Bioscience, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales 1.3× against a median of 2.2×: 4th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $258.2M TWD
- P/E
- Loss
- EV/sales
- 1.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.6×
- Gross margin
- 19.1%
- Operating margin
- −40.4%
- Net margin
- −38.6%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| TFBS Bioscience, Inc. · TPEX:6939 | US$19.81M | US$7.83M | n/a | 1.3× | n/a | 0.6× | −38.6% | 0.0× | n/a |
| Biosino Bio-Technology & Science, Inc. Class H · HKEX:8247 | US$21.28M | US$19.44M | n/a | 0.7× | n/a | 1.3× | −27.8% | 0.1× | n/a |
| GeneReach Biotechnology Corp. · TPEX:4171 | US$21.05M | US$9.04M | n/a | 1.3× | 222× | 1.2× | −18.1% | 0.0× | n/a |
| IVIM Technology, Inc. · KRX:460470 | US$20.68M | US$10.37M | n/a | 2.1× | n/a | 1.1× | −40.9% | 0.0× | n/a |
| Q-linea AB · OMXSTO:QLINEA | US$20.66M | US$7.57M | n/a | 6.9× | n/a | 0.9× | n/a | 0.1× | n/a |
| SANIGEN Co., Ltd. · KRX:188260 | US$19.66M | US$10.06M | n/a | 2.2× | n/a | 2.3× | −82.6% | 0.1× | n/a |
| NanoRepro AG · XETR:NN6 | US$19.45M | US$11.45M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | n/a |
| Urteste S.A. · GPW:URT | US$19.24M | US$19.10M | n/a | 3,525× | n/a | 3.5× | n/a | 0.0× | n/a |
| Genematrix Inc. · KRX:109820 | US$19.06M | US$6.80M | n/a | 0.8× | 31.7× | 1.4× | −1.7% | 0.0× | n/a |
| Oxford BioDynamics PLC · LSE:OBD | US$18.46M | US$20.77M | n/a | 14.5× | n/a | 4.3× | n/a | 1.3× | n/a |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALB | US$18.41M | US$16.94M | 1.1× | 3.6× | 61.6× | 0.3× | 367.8% | 0.0× | n/a |
| Median of the others | US$19.56M | US$10.91M | 1.1× | 2.2× | 61.6× | 1.2× | −22.9% | 0.0× |
Team and board
Officers
| Officer | Role |
|---|---|
| Tatung Yuan | Chairman and Chief Executive Officer |
| Wilson Liao | Chief Financial Officer |
| Seigyoku Ryu | Vice President, TFBS BIOSCIENCE Japan |
| Chia-Hsin Li | Director, Testing Service Department |
| Esther Chiu | Senior Manager, Quality Assurance department |
| Gabriel Wu | Director, Manufacturing Department |
| Man-Shiow Jiang | Chief Technology Officer |
| Shao-Hua Lo | Director, Business Development Department |
Board
| Director | Role |
|---|---|
| Tatung Yuan | Chairman and Chief Executive Officer |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 193.1M | 180.6M | 231.9M | 252.7M | 160.9M | 118.6M |
| Cost of revenue | 156.3M | 143.0M | 168.6M | 148.7M | 106.8M | 84.0M |
| Gross profit | 36.8M | 37.5M | 63.3M | 104.0M | 54.0M | 34.6M |
| Research and development | 64.8M | 45.7M | 36.2M | 33.7M | 26.0M | 21.0M |
| Selling, general and administrative | 50.0M | 40.4M | 40.8M | 36.6M | 22.1M | |
| Operating income | -78.0M | -61.2M | -5.45M | 33.8M | 6.01M | 311.0K |
| Depreciation and amortization | 51.9M | 50.4M | 58.8M | 37.0M | 25.4M | 25.2M |
| EBITDA | -26.1M | -10.9M | 53.3M | 70.7M | 31.4M | 25.5M |
| Interest expense | 2.81M | 841.0K | 602.0K | 647.0K | 306.0K | 357.0K |
| Income before tax | -73.9M | -49.0M | 4.77M | 30.7M | 7.01M | 334.0K |
| Income tax | -10.3M | -135.0K | 3.02M | 886.0K | 38.0K | |
| Net income | -74.5M | -38.7M | 4.91M | 27.7M | 6.12M | 296.0K |
| Earnings per share, basic | -2.13 | -1.11 | 0.14 | 0.80 | 0.18 | 0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 307.3M | 515.9M | 929.3M | 976.4M | 240.9M | 76.1M |
| Short-term investments | 133.5M | 178.0M | 50.0M | 50.0M | ||
| Receivables | 23.9M | 49.3M | 80.8M | 79.8M | 60.8M | 94.0K |
| Inventory | 13.9M | 12.9M | 8.84M | 5.69M | 5.86M | |
| Current assets | 523.1M | 776.3M | 1.07B | 1.11B | 308.5M | 104.6M |
| Total assets | 1.46B | 1.50B | 1.45B | 1.36B | 491.3M | 288.4M |
| Accounts payable | 7.98M | 9.50M | 8.71M | 11.2M | 15.5M | 8.67M |
| Current liabilities | 200.3M | 188.7M | 84.9M | 103.8M | 50.5M | 26.6M |
| Total debt | 196.2M | 131.8M | 52.2M | 21.4M | 19.7M | |
| Total liabilities | 294.7M | 265.1M | 187.4M | 126.2M | 66.4M | 40.4M |
| Shareholders' equity | 1.16B | 1.23B | 1.26B | 1.24B | 424.9M | 247.9M |
| Shares outstanding | 35.0M | 34.8M | 35.1M | 34.8M | 34.8M | 34.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -9.74M | 28.8M | 36.5M | 78.7M | 21.0M | 29.4M |
| Capital spending | -225.4M | -372.8M | -55.9M | -49.8M | -19.0M | -13.3M |
| Free cash flow | -235.2M | -344.0M | -19.4M | 28.9M | 1.98M | 16.1M |
| Cash from investing | -501.0M | -57.6M | -104.7M | -19.4M | -12.8M | |
| Cash from financing | 60.5M | -26.0M | 761.6M | 163.1M | -6.87M | |
| Dividends paid | -1.74M | -3.35M | ||||
| Change in cash | -208.6M | -413.4M | -47.1M | 735.5M | 164.8M | 9.77M |
Cap table
Built by 6ix from TFBS Bioscience, Inc.’s releases
- Common shares
- 35,384,161
- Fully diluted
- 35,384,161
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 35,384,161 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 35,384,161 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Chia-Hsin Li | Director, Testing Service Department · Since at least Nov 5, 2026 |
| Esther Chiu | Senior Manager, Quality Assurance department · Since at least Nov 5, 2026 |
| Gabriel Wu | Director, Manufacturing Department · Since at least Nov 5, 2026 |
| Man-Shiow Jiang | Chief Technology Officer · Since at least Nov 5, 2026 |
| Seigyoku Ryu | Vice President, TFBS BIOSCIENCE Japan · Since at least Nov 5, 2026 |
| Shao-Hua Lo | Director, Business Development Department · Since at least Nov 5, 2026 |
| Tatung Yuan | Chairman and Chief Executive Officer · Since at least Nov 5, 2026 |
| Wilson Liao | Chief Financial Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about TFBS Bioscience, Inc.